BioCentury
ARTICLE | Clinical News

Lucanix belagenpumatucel-L: Phase III data

September 30, 2013 7:00 AM UTC

The double-blind, international Phase III STOP trial in 532 patients with stage III/IV NSCLC who have responded to or have stable disease following 1 regimen of first-line platinum-based chemotherapy ...